MYH7 and cardiac hypertrophy: Maeda et al. [36] suggested that TEAD-3 mediates α1-adrenaline signals, which play a pivotal role in pathological cardiac hypertrophy accompanied with increases in the expression of MYH7 [2], [32], [37].